EMA Offers Support for More Research on DIVI Biomarkers
By Zachary Brennan -
Published 09 November 2017
European Medicines Agency (EMA) Executive Director Guido Rasi this week sent a letter of support to the Safer and Faster Evidence-Based Translation (SAFE-T) Consortium and the Predictive Safety Testing Consortium (PSTC) to encourage further study of ways to monitor for drug-induced vascular injury (DIVI) in early clinical drug development.
Categories: News, Europe, US, EMA, FDA, Clinical, Government affairs, Research and development
Tags: Guido Rasi, DIVI biomarkers